OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Human phase‐I metabolism and prevalence of two synthetic cannabinoids bearing an ethyl ester moiety: 5F‐EDMB‐PICA and EDMB‐PINACA
Arianna Giorgetti, Pietro Brunetti, Belal Haschimi, et al.
Drug Testing and Analysis (2022) Vol. 15, Iss. 3, pp. 299-313
Open Access | Times Cited: 11
Arianna Giorgetti, Pietro Brunetti, Belal Haschimi, et al.
Drug Testing and Analysis (2022) Vol. 15, Iss. 3, pp. 299-313
Open Access | Times Cited: 11
Showing 11 citing articles:
ADB‐HEXINACA—a novel synthetic cannabinoid with a hexyl substituent: phase I metabolism in authentic urine samples, a case report and prevalence on the German market
Arianna Giorgetti, Annette Zschiesche, Olwen Groth, et al.
Drug Testing and Analysis (2024) Vol. 16, Iss. 11, pp. 1350-1365
Open Access | Times Cited: 5
Arianna Giorgetti, Annette Zschiesche, Olwen Groth, et al.
Drug Testing and Analysis (2024) Vol. 16, Iss. 11, pp. 1350-1365
Open Access | Times Cited: 5
Metabolism of ADB‐FUBIATA in zebrafish and pooled human liver microsomes investigated by liquid chromatography–high‐resolution mass spectrometry
Xinze Liu, Yiling Tang, Linhao Xu, et al.
Rapid Communications in Mass Spectrometry (2024) Vol. 38, Iss. 9
Closed Access | Times Cited: 3
Xinze Liu, Yiling Tang, Linhao Xu, et al.
Rapid Communications in Mass Spectrometry (2024) Vol. 38, Iss. 9
Closed Access | Times Cited: 3
The metabolic profile of the synthetic cannabinoid receptor agonist ADB-HEXINACA using human hepatocytes, LC–QTOF-MS and synthesized reference standards
Steven Baginski, Tobias Rautio, Lorna A. Nisbet, et al.
Journal of Analytical Toxicology (2023) Vol. 47, Iss. 9, pp. 826-834
Open Access | Times Cited: 8
Steven Baginski, Tobias Rautio, Lorna A. Nisbet, et al.
Journal of Analytical Toxicology (2023) Vol. 47, Iss. 9, pp. 826-834
Open Access | Times Cited: 8
Detecting novel psychoactive substances around the world
Alberto Salomone, Marco Vincenti
Current Opinion in Psychiatry (2024) Vol. 37, Iss. 4, pp. 258-263
Closed Access | Times Cited: 2
Alberto Salomone, Marco Vincenti
Current Opinion in Psychiatry (2024) Vol. 37, Iss. 4, pp. 258-263
Closed Access | Times Cited: 2
Metabolism of Six Novel Nitazenes in Human Liver Microsomes Based on Ultra‐High‐Performance Liquid Chromatography Coupled With High‐Resolution Mass Spectrometry
Boxian Huang, Zhendong Hua, Cuimei Liu, et al.
Drug Testing and Analysis (2024)
Open Access | Times Cited: 2
Boxian Huang, Zhendong Hua, Cuimei Liu, et al.
Drug Testing and Analysis (2024)
Open Access | Times Cited: 2
Human metabolism and basic pharmacokinetic evaluation of AP‐238: A recently emerged acylpiperazine opioid
Pietro Brunetti, Diletta Berardinelli, Arianna Giorgetti, et al.
Drug Testing and Analysis (2023) Vol. 16, Iss. 2, pp. 221-235
Open Access | Times Cited: 4
Pietro Brunetti, Diletta Berardinelli, Arianna Giorgetti, et al.
Drug Testing and Analysis (2023) Vol. 16, Iss. 2, pp. 221-235
Open Access | Times Cited: 4
Insights into the metabolism of CH-PIATA—A novel synthetic cannabinoid featuring an acetamide linker
Annette Zschiesche, Martin Scheu, Detlef Thieme, et al.
Journal of Analytical Toxicology (2024) Vol. 48, Iss. 5, pp. 359-371
Closed Access | Times Cited: 1
Annette Zschiesche, Martin Scheu, Detlef Thieme, et al.
Journal of Analytical Toxicology (2024) Vol. 48, Iss. 5, pp. 359-371
Closed Access | Times Cited: 1
Human phase‐I metabolism of three synthetic cannabinoids bearing a cumyl moiety and a cyclobutyl methyl or norbornyl methyl tail: Cumyl‐CBMEGACLONE, Cumyl‐NBMEGACLONE, and Cumyl‐NBMINACA
Arianna Giorgetti, Pietro Brunetti, Belal Haschimi, et al.
Drug Testing and Analysis (2024)
Open Access | Times Cited: 1
Arianna Giorgetti, Pietro Brunetti, Belal Haschimi, et al.
Drug Testing and Analysis (2024)
Open Access | Times Cited: 1
Assessment of pharmacological effects and abuse potential of 5F-EDMB-PICA, CUMYL-PEGACLONE, and NM-2201 in mice
Kaixi Li, Deli Xu, Yanling Qiao, et al.
Psychopharmacology (2024)
Closed Access | Times Cited: 1
Kaixi Li, Deli Xu, Yanling Qiao, et al.
Psychopharmacology (2024)
Closed Access | Times Cited: 1
Identification of phase-I and phase-II metabolites and the metabolic pathway of the novel synthetic cannabinoid 5F-EDMB-PICA in vitro
Yujie Gao, Kaiting Shi, Peipei Wang, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 9, pp. 2879-2888
Closed Access
Yujie Gao, Kaiting Shi, Peipei Wang, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 9, pp. 2879-2888
Closed Access
Synthesis and structure-affinity relationships of spirocyclic σ1 receptor ligands with tetrahydropyran scaffold
Tobias Winge, Dirk Schepmann, Judith Schmidt, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117002-117002
Open Access
Tobias Winge, Dirk Schepmann, Judith Schmidt, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117002-117002
Open Access
